Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

HSCA Applauds House Judiciary Committee for Advancing the CREATES Act

April 30, 2019 by Elizabeth Landau Uncategorized 0 comments

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO
Khatereh Calleja today released the following statement applauding the House Judiciary Committee
members for voting to advance the CREATES Act (H.R. 965):

“The Healthcare Supply Chain Association (HSCA) and its member group purchasing organizations
(GPOs) applaud Chairman Nadler, Ranking Member Collins, and the members of the House Judiciary
Committee for helping to increase competition in the generic drug marketplace by voting to advance the
CREATES Act. Americans rely on generic drugs to reduce costs and increase access to necessary
medication, and price spikes for commonly used drugs jeopardize patient access to care. HSCA supports
policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in
the marketplace, and end anti-competitive abuses utilized by some brand-name manufacturers. We
urge the House to quickly pass the CREATES Act to protect patient access to essential medications.”

 

Read the full statement here.

Prev
Next

Related Posts

HSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
June 29, 2020

Dear Chairman Alexander and Ranking Member Murray: On behalf of the...

Learn more
HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
February 5, 2021

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020

Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on President Biden’s Executive Order on America’s Supply Chains
    February 25, 2021
  • HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
    February 5, 2021